Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Treating sickle cell disease by targeting HbS polymerization
source: Blood
year: 2017
authors: Eaton WA, Bunn HF
summary/abstract:Although the root cause of sickle cell disease is the polymerization of hemoglobin S (HbS) to form fibers that make red cells less flexible, most drugs currently being assessed in clinical trials are targeting the downstream sequelae of this primary event. Less attention has been devoted to investigation of the multiple ways in which fiber formation can be inhibited. In this article, we describe the molecular rationale for 5 distinct approaches to inhibiting polymerization and also discuss progress with the few antipolymerization drugs currently in clinical trials.
organization: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda; Brigham and Women's Hospital, Boston; Harvard Medical School, BostonDOI: 10.1182/blood-2017-02-765891
read more full text
+myBinderRelated Content
-
Small chips, big impact: MSU researcher studies cardiovascular, sickle cell diseaseA Mississippi State University researche...
-
Role of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expre...Despite the detailed characterization of...
-
Healthy red blood cells owe their shape to muscle-like structuresRed blood cells are on a wild ride. As t...
-
Orphan Drugs for Sickle Vaso-occlusion: Dawn of a New Era of Targeted TreatmentWhile an orphan disease in the USA, sick...
-
Marina Jerebtsova, PhDDr Marina Jerebtsova is an assistant pro...
-
Chip-based Models Mimic Organs to Advance Understanding of Sickle Cell DiseaseResearchers at Mississippi State Univers...
-
Computer models provide new understanding of sickle cell diseaseComputer models developed by Brown Unive...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.